Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sarfez Pharma’s Promotional Claims For Diuretic Soaanz Draw US FDA Warning Letter
May 22 2025
•
By
Sue Sutter
Claims that Soaanz does not cause excessive urination are not supported, FDA said.
(Shutterstock)
More from Marketing & Advertising
More from Compliance